Abstract CT267: First results of ART0380 (an ATR kinase inhibitor) with low dose irinotecan in advanced or metastatic solid tumorsSusanna V. Ulahannan, Babar Bashir, Kathleen N. Moore et al.|Cancer Research|2025Cited by 3